A study examines the special needs and risks for people with Type 1 diabetes in nursing homes.
The new law is designed to streamline clinical trials and encourage investment in new treatments.
Australian researchers discovered this. Of course they did – it’s Australia.
And, without irony, It cites lower prices for injectable insulin as one of the reasons why.
If successful, the system would be the first to use both glucagon and insulin to make it to market.
They uncover two proteins that would detect nephropathy before a urine test would detect damage.
Researchers devise smaller particles that could deliver medication in a better way.
A new study reveals that treating people with MODY with some Type 2 treatments can curb natural insulin production.
A beginning comparison between two artificial pancreas systems.
It’s part of the company’s effort to retool after taking back control of the drug from Sanofi.
A new study finds it’s bad for you. But you knew that already, didn’t you?
The FDA fast-tracks a treatment that would, in theory, use T cells to stop Type 1 diabetes in its tracks
A trial participant shares her experience, and her hope for the experimental system’s success.
The company plans to submit the pump system for FDA approval in 2017.
German researchers test whether such screening leads to better health outcomes for children with Type 1 and their parents.
Parent-to-parent mentoring may help parents provide improved care to children recently diagnosed with Type 1 diabetes.
Newsflash – diabetes is expensive. (Sigh.)
In a new study, researchers suggest that better sanitation and hygiene standards might be the culprit.
He is the second patient to be successfully treated by the experimental treatment, which was invented by the Diabetes Research Institute.
Researchers find they are three times more likely to develop the condition than the average population.